Recordati AGBasel, Switzerland
Disclosure information not submitted.
SAT-036 - Osilodrostat Treatment Outcomes Across Various Etiologies and Severities of Cushing'S Syndrome: LINC 7 Secondary Analysis
Saturday, June 13, 20269:30 AM - 4:30 PM CT